Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 1, 2025 | Cat | Cat (other) | Frunevetmab | Swollen joint; Bone and joint disorder NOS; Limb amputation | Ongoing |
| May 1, 2025 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (endoparasite) - NOS | Ongoing |
| May 1, 2025 | Cat | Cat (unknown) | Molidustat Sodium | Food refusal; Weakness; Limb weakness; Weight loss; Anaemia NOS | Outcome Unknown |
| May 1, 2025 | Cat | Siamese | Selamectin;Sarolaner | Application site hair loss; Application site bleeding; Application site itching | Ongoing |
| May 1, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Sleepiness - systemic disorder | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | High pancreatic-specific lipase | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; UNPALATABLE; Product defect, product difficult to use/handle (see ... | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Laboured breathing; Cough; Pulmonary oedema | Recovered/Normal |
| May 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Excoriation | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Weight loss; Lack of efficacy - NOS | Ongoing |
| May 1, 2025 | Cat | Maine Coon | Fluralaner/Moxidectin Spot-On | Application site itching; Application site twitching; Drug administered at in... | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Cough; Abnormal radiograph finding | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Application site alopecia | Ongoing |
| May 1, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Application site hair loss | Outcome Unknown |
| May 1, 2025 | Cat | Russian | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Swollen joint; Joint pain; Bone and joint disorder NOS | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Loose stool; Digestive tract disorder NOS | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Nitenpyram | Lack of efficacy (ectoparasite) - flea; Administration error NOS | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Nitenpyram | Lack of efficacy (ectoparasite) - flea; Administration error NOS | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Increased drinking; Weight loss; Frequent urination; Loose stool | Ongoing |
| May 1, 2025 | Cat | Domestic Mediumhair | Frunevetmab | Weight loss; Polydipsia; Hypokalaemia; Other abnormal test result NOS | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Lotilaner | Hot spot (pyotraumatic dermatitis); Grooming disorder; Alopecia; Scratching; ... | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis; Lack of efficacy - NOS; Weight loss | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Mediumhair | Bexagliflozin | Weight loss; Elevated symmetrical dimethylarginine (SDMA); Elevated creatinin... | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Cyclosporine | Ketosis | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Partial anorexia; Loose stool | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Vomiting; Weight loss | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Pain NOS; Pyelonephritis; Blood clot; Constipation; Malaise; Blood in urine; ... | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Hyperthyroidism; Tachycardia; Open mouth breathing; Cardiac enlargement; Pleu... | Ongoing |
| May 1, 2025 | Cat | Domestic Mediumhair | Frunevetmab | Skin scab; Skin ulcer; Crust; Abnormal cytology; Ear infection NOS; Scratchin... | Ongoing |
| May 1, 2025 | Cat | Crossbred Feline/cat | Selamectin;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Not hi... | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Frunevetmab | Diarrhoea | Recovered/Normal |
| May 1, 2025 | Cat | Crossbred Feline/cat | Frunevetmab | Hiding; Not eating; Weight loss; Hind limb paresis; Circling - neurological d... | Ongoing |
| Apr 30, 2025 | Cat | Domestic Shorthair | Frunevetmab | Heart failure; Pneumonia; Death by euthanasia; Overdose | Euthanized |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site reddening; Application site burn | Ongoing |
| Apr 30, 2025 | Cat | Domestic Shorthair | Maropitant Citrate | Weight loss; Foaming at the mouth | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Capromorelin | Weight loss; Foaming at the mouth | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site hair loss; Application site burn | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Fenbendazol Granules | Weight loss; Foaming at the mouth | Outcome Unknown |
| Apr 30, 2025 | Cat | Russian | Selamectin;Sarolaner | Application site alopecia; Application site reddening; Skin lesion NOS | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site hair loss; Application site scab; Application site reddening | Ongoing |
| Apr 30, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Seizure NOS | Ongoing |
| Apr 30, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Hypersalivation | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Protamine Zinc Recombinant Human Insulin | Lack of efficacy - NOS | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site skin discolouration | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Frunevetmab | Partial lack of efficacy | Ongoing |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site pruritus; Application site bleeding | Ongoing |
| Apr 30, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Ketosis; High pancreatic-specific lipase; Anorexia; Adipsia; Death by euthana... | Euthanized |
| Apr 30, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketonuria | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.